Skip to main content
Erschienen in: Clinical Research in Cardiology 11/2010

01.11.2010 | Original Paper

Admission glucose level and in-hospital outcomes in diabetic and non-diabetic patients with acute myocardial infarction

verfasst von: Artur Dziewierz, Dawid Giszterowicz, Zbigniew Siudak, Tomasz Rakowski, Jacek S. Dubiel, Dariusz Dudek

Erschienen in: Clinical Research in Cardiology | Ausgabe 11/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

Hyperglycemia on admission is a predictor of unfavorable prognosis in patients with acute myocardial infarction (AMI). Data concerning associations between elevated glucose level on admission and other in-hospital complications are still limited.

Methods

A total of 607 AMI patients with complete admission glucose data in the Krakow Registry of Acute Coronary Syndromes were identified and were stratified according to glucose admission level.

Results

A total of 71.5% of patients were with admission glucose level <7.8 mmol/l, 17.6% of patients with 7.8–11.0 mmol/l, and 10.9% of patients with ≥11.1 mmol/l. In-hospital mortality for patients treated conservatively was higher in patients with higher admission glucose (8.0 vs. 25.0 vs. 39.1%, respectively, P < 0.0001), and significant mortality difference was confirmed both for diabetic and non-diabetic patients. Admission hyperglycemia was associated with increased risk of ventricular tachycardia/ventricular fibrillation, atrial fibrillation, second to third atriventricular block, pulmonary oeadema, but not ischemic stroke and blood transfusion during index hospital stay.

Conclusions

Elevated admission glucose levels are associated with increased risk of life-threatening complications, especially arrhythmias in diabetic and non-diabetic AMI patients. This increased risk of complications is one of the possible explanations for the elevated in-hospital mortality in AMI patients presenting with hyperglycemia.
Literatur
1.
Zurück zum Zitat Capes SE, Hunt D, Malmberg K, Gerstein HC (2000) Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355:773–778CrossRefPubMed Capes SE, Hunt D, Malmberg K, Gerstein HC (2000) Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355:773–778CrossRefPubMed
2.
Zurück zum Zitat Kosiborod M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP, Krumholz HM (2005) Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 111:3078–3086CrossRefPubMed Kosiborod M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP, Krumholz HM (2005) Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 111:3078–3086CrossRefPubMed
3.
Zurück zum Zitat Kosiborod M, Inzucchi SE, Krumholz HM, Xiao L, Jones PG, Fiske S, Masoudi FA, Marso SP, Spertus JA (2008) Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation 117:1018–1027CrossRefPubMed Kosiborod M, Inzucchi SE, Krumholz HM, Xiao L, Jones PG, Fiske S, Masoudi FA, Marso SP, Spertus JA (2008) Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation 117:1018–1027CrossRefPubMed
4.
Zurück zum Zitat Stranders I, Diamant M, van Gelder RE, Spruijt HJ, Twisk JW, Heine RJ, Visser FC (2004) Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med 164:982–988CrossRefPubMed Stranders I, Diamant M, van Gelder RE, Spruijt HJ, Twisk JW, Heine RJ, Visser FC (2004) Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med 164:982–988CrossRefPubMed
5.
Zurück zum Zitat Petursson P, Herlitz J, Caidahl K, Gudbjornsdottir S, Karlsson T, Perers E, Sjoland H, Hartford M (2007) Admission glycaemia and outcome after acute coronary syndrome. Int J Cardiol 116:315–320CrossRefPubMed Petursson P, Herlitz J, Caidahl K, Gudbjornsdottir S, Karlsson T, Perers E, Sjoland H, Hartford M (2007) Admission glycaemia and outcome after acute coronary syndrome. Int J Cardiol 116:315–320CrossRefPubMed
6.
Zurück zum Zitat Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T, Raskin P (2008) Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on nutrition, physical activity, and metabolism. Circulation 117:1610–1619CrossRefPubMed Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T, Raskin P (2008) Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on nutrition, physical activity, and metabolism. Circulation 117:1610–1619CrossRefPubMed
7.
Zurück zum Zitat Koracevic GP, Petrovic S, Damjanovic M, Stanojlovic T (2008) Association of stress hyperglycemia and atrial fibrillation in myocardial infarction. Wien Klin Wochenschr 120:409–413CrossRefPubMed Koracevic GP, Petrovic S, Damjanovic M, Stanojlovic T (2008) Association of stress hyperglycemia and atrial fibrillation in myocardial infarction. Wien Klin Wochenschr 120:409–413CrossRefPubMed
8.
Zurück zum Zitat Dudek D, Siudak Z, Kuta M, Dziewierz A, Mielecki W, Rakowski T, Giszterowicz D, Dubiel JS (2006) Management of myocardial infarction with ST-segment elevation in district hospitals without catheterisation laboratory—Acute Coronary Syndromes Registry of Malopolska 2002–2003. Kardiol Pol 64:1053–1060PubMed Dudek D, Siudak Z, Kuta M, Dziewierz A, Mielecki W, Rakowski T, Giszterowicz D, Dubiel JS (2006) Management of myocardial infarction with ST-segment elevation in district hospitals without catheterisation laboratory—Acute Coronary Syndromes Registry of Malopolska 2002–2003. Kardiol Pol 64:1053–1060PubMed
9.
Zurück zum Zitat Dziewierz A, Siudak Z, Rakowski T, Mielecki W, Giszterowicz D, Dubiel JS, Dudek D (2007) More aggressive pharmacological treatment may improve clinical outcome in patients with non-ST-elevation acute coronary syndromes treated conservatively. Coron Artery Dis 18:299–303CrossRefPubMed Dziewierz A, Siudak Z, Rakowski T, Mielecki W, Giszterowicz D, Dubiel JS, Dudek D (2007) More aggressive pharmacological treatment may improve clinical outcome in patients with non-ST-elevation acute coronary syndromes treated conservatively. Coron Artery Dis 18:299–303CrossRefPubMed
10.
Zurück zum Zitat Dudek D, Siudak Z, Dziewierz A, Rakowski T, Mielecki W, Brzeziński M, Zasada W, Janus B, Bartus S, Dubiel JS ((2008)) Creating local hospital networks for STEMI treatment for a population of 0.5 million increases invasive treatment of acute coronary syndromes to the European reccomended level. The Malopolska Registry of Acute Coronary Syndromes 2005–2006. Kardiol Pol 66:489–497 Dudek D, Siudak Z, Dziewierz A, Rakowski T, Mielecki W, Brzeziński M, Zasada W, Janus B, Bartus S, Dubiel JS ((2008)) Creating local hospital networks for STEMI treatment for a population of 0.5 million increases invasive treatment of acute coronary syndromes to the European reccomended level. The Malopolska Registry of Acute Coronary Syndromes 2005–2006. Kardiol Pol 66:489–497
11.
Zurück zum Zitat Nieminen MS, Bohm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, Hasin Y, Lopez-Sendon J, Mebazaa A, Metra M, Rhodes A, Swedberg K, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie MR, Dean V, Deckers J, Burgos EF, Lekakis J, Lindahl B, Mazzotta G, Morais J, Oto A, Smiseth OA, Garcia MA, Dickstein K, Albuquerque A, Conthe P, Crespo-Leiro M, Ferrari R, Follath F, Gavazzi A, Janssens U, Komajda M, Morais J, Moreno R, Singer M, Singh S, Tendera M, Thygesen K (2005) Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the task force on acute heart failure of the European Society of Cardiology. Eur Heart J 26:384–416CrossRefPubMed Nieminen MS, Bohm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, Hasin Y, Lopez-Sendon J, Mebazaa A, Metra M, Rhodes A, Swedberg K, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie MR, Dean V, Deckers J, Burgos EF, Lekakis J, Lindahl B, Mazzotta G, Morais J, Oto A, Smiseth OA, Garcia MA, Dickstein K, Albuquerque A, Conthe P, Crespo-Leiro M, Ferrari R, Follath F, Gavazzi A, Janssens U, Komajda M, Morais J, Moreno R, Singer M, Singh S, Tendera M, Thygesen K (2005) Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the task force on acute heart failure of the European Society of Cardiology. Eur Heart J 26:384–416CrossRefPubMed
12.
Zurück zum Zitat DR Holmes Jr, Berger PB, Hochman JS, Granger CB, Thompson TD, Califf RM, Vahanian A, Bates ER, Topol EJ (1999) Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation. Circulation 100:2067–2073 DR Holmes Jr, Berger PB, Hochman JS, Granger CB, Thompson TD, Califf RM, Vahanian A, Bates ER, Topol EJ (1999) Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation. Circulation 100:2067–2073
13.
Zurück zum Zitat Steg PG, Goldberg RJ, Gore JM, Fox KA, Eagle KA, Flather MD, Sadiq I, Kasper R, Rushton-Mellor SK, Anderson FA (2002) Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol 90:358–363CrossRefPubMed Steg PG, Goldberg RJ, Gore JM, Fox KA, Eagle KA, Flather MD, Sadiq I, Kasper R, Rushton-Mellor SK, Anderson FA (2002) Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol 90:358–363CrossRefPubMed
14.
Zurück zum Zitat Salisbury AC, Reid KJ, Spertus JA (2007) Impact of chronic obstructive pulmonary disease on post-myocardial infarction outcomes. Am J Cardiol 99:636–641CrossRefPubMed Salisbury AC, Reid KJ, Spertus JA (2007) Impact of chronic obstructive pulmonary disease on post-myocardial infarction outcomes. Am J Cardiol 99:636–641CrossRefPubMed
15.
Zurück zum Zitat Dziewierz A, Siudak Z, Rakowski T, Zdzienicka J, Dykla D, Mielecki W, Dubiel JS, Dudek D (2008) In-hospital management and mortality in elderly patients with non-ST-segment elevation acute coronary syndromes treated in centers without on-site invasive facilities. Cardiol J 15:451–457PubMed Dziewierz A, Siudak Z, Rakowski T, Zdzienicka J, Dykla D, Mielecki W, Dubiel JS, Dudek D (2008) In-hospital management and mortality in elderly patients with non-ST-segment elevation acute coronary syndromes treated in centers without on-site invasive facilities. Cardiol J 15:451–457PubMed
16.
Zurück zum Zitat Avezum A, Makdisse M, Spencer F, Gore JM, Fox KA, Montalescot G, Eagle KA, White K, Mehta RH, Knobel E, Collet JP (2005) Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 149:67–73CrossRefPubMed Avezum A, Makdisse M, Spencer F, Gore JM, Fox KA, Montalescot G, Eagle KA, White K, Mehta RH, Knobel E, Collet JP (2005) Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 149:67–73CrossRefPubMed
17.
Zurück zum Zitat Lankisch M, Futh R, Gulker H, Lapp H, Bufe A, Haastert B, Martin S, Rathmann W (2008) Screening for undiagnosed diabetes in patients with acute myocardial infarction. Clin Res Cardiol 97:753–759CrossRefPubMed Lankisch M, Futh R, Gulker H, Lapp H, Bufe A, Haastert B, Martin S, Rathmann W (2008) Screening for undiagnosed diabetes in patients with acute myocardial infarction. Clin Res Cardiol 97:753–759CrossRefPubMed
18.
Zurück zum Zitat Timmer JR, Ottervanger JP, de Boer MJ, Dambrink JH, Hoorntje JC, Gosselink AT, Suryapranata H, Zijlstra F, van‘t Hof AW (2005) Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction. J Am Coll Cardiol 45:999–1002CrossRefPubMed Timmer JR, Ottervanger JP, de Boer MJ, Dambrink JH, Hoorntje JC, Gosselink AT, Suryapranata H, Zijlstra F, van‘t Hof AW (2005) Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction. J Am Coll Cardiol 45:999–1002CrossRefPubMed
19.
Zurück zum Zitat Undas A, Wiek I, Stepien E, Zmudka K, Tracz W (2008) Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome. Diabetes Care 31:1590–1595CrossRefPubMed Undas A, Wiek I, Stepien E, Zmudka K, Tracz W (2008) Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome. Diabetes Care 31:1590–1595CrossRefPubMed
20.
Zurück zum Zitat Gresele P, Guglielmini G, De Angelis M, Ciferri S, Ciofetta M, Falcinelli E, Lalli C, Ciabattoni G, Davi G, Bolli GB (2003) Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. J Am Coll Cardiol 41:1013–1020CrossRefPubMed Gresele P, Guglielmini G, De Angelis M, Ciferri S, Ciofetta M, Falcinelli E, Lalli C, Ciabattoni G, Davi G, Bolli GB (2003) Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. J Am Coll Cardiol 41:1013–1020CrossRefPubMed
21.
Zurück zum Zitat Ray KK, Cannon CP, Morrow DA, Kirtane AJ, Buros J, Rifai N, McCabe CH, Gibson CM, Braunwald E (2007) Synergistic relationship between hyperglycaemia and inflammation with respect to clinical outcomes in non-ST-elevation acute coronary syndromes: analyses from OPUS-TIMI 16 and TACTICS-TIMI 18. Eur Heart J 28:806–813CrossRefPubMed Ray KK, Cannon CP, Morrow DA, Kirtane AJ, Buros J, Rifai N, McCabe CH, Gibson CM, Braunwald E (2007) Synergistic relationship between hyperglycaemia and inflammation with respect to clinical outcomes in non-ST-elevation acute coronary syndromes: analyses from OPUS-TIMI 16 and TACTICS-TIMI 18. Eur Heart J 28:806–813CrossRefPubMed
22.
Zurück zum Zitat Segev A, Strauss BH, Tan M, Buller CE, Mendelsohn AA, Langer A, Goodman SG (2008) Risk factors and outcome of in-hospital ischemic stroke in patients with non-ST elevation acute coronary syndromes. Int J Cardiol 129:233–237CrossRefPubMed Segev A, Strauss BH, Tan M, Buller CE, Mendelsohn AA, Langer A, Goodman SG (2008) Risk factors and outcome of in-hospital ischemic stroke in patients with non-ST elevation acute coronary syndromes. Int J Cardiol 129:233–237CrossRefPubMed
23.
Zurück zum Zitat Rao SV, Jollis JG, Harrington RA, Granger CB, Newby LK, Armstrong PW, Moliterno DJ, Lindblad L, Pieper K, Topol EJ, Stamler JS, Califf RM (2004) Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 292:1555–1562CrossRefPubMed Rao SV, Jollis JG, Harrington RA, Granger CB, Newby LK, Armstrong PW, Moliterno DJ, Lindblad L, Pieper K, Topol EJ, Stamler JS, Califf RM (2004) Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 292:1555–1562CrossRefPubMed
24.
Zurück zum Zitat Eikelboom JW, Mehta SR, Anand SS, Xie C, Fox KA, Yusuf S (2006) Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation 114:774–782CrossRefPubMed Eikelboom JW, Mehta SR, Anand SS, Xie C, Fox KA, Yusuf S (2006) Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation 114:774–782CrossRefPubMed
25.
Zurück zum Zitat Avezum A, Piegas LS, Goldberg RJ, Brieger D, Stiles MK, Paolini R, Huang W, Gore JM (2008) Magnitude and prognosis associated with ventricular arrhythmias in patients hospitalized with acute coronary syndromes (from the GRACE Registry). Am J Cardiol 102:1577–1582CrossRefPubMed Avezum A, Piegas LS, Goldberg RJ, Brieger D, Stiles MK, Paolini R, Huang W, Gore JM (2008) Magnitude and prognosis associated with ventricular arrhythmias in patients hospitalized with acute coronary syndromes (from the GRACE Registry). Am J Cardiol 102:1577–1582CrossRefPubMed
26.
Zurück zum Zitat Ngarmukos T, Sriratanasthavorn C, Sansaneevithayakul B, Kasemsuwan P, Angkasuwapala K, Yamwong S (2007) Cardiac arrhythmias in Thai Acute Coronary Syndrome Registry. J Med Assoc Thai 90(Suppl 1):58–64 Ngarmukos T, Sriratanasthavorn C, Sansaneevithayakul B, Kasemsuwan P, Angkasuwapala K, Yamwong S (2007) Cardiac arrhythmias in Thai Acute Coronary Syndrome Registry. J Med Assoc Thai 90(Suppl 1):58–64
27.
Zurück zum Zitat Lopes RD, Pieper KS, Horton JR, Al-Khatib SM, Newby LK, Mehta RH, Van de WF, Armstrong PW, Mahaffey KW, Harrington RA, Ohman EM, White HD, Wallentin L, Granger CB (2008) Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation. Heart 94:867–873CrossRefPubMed Lopes RD, Pieper KS, Horton JR, Al-Khatib SM, Newby LK, Mehta RH, Van de WF, Armstrong PW, Mahaffey KW, Harrington RA, Ohman EM, White HD, Wallentin L, Granger CB (2008) Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation. Heart 94:867–873CrossRefPubMed
28.
Zurück zum Zitat Pizzetti F, Turazza FM, Franzosi MG, Barlera S, Ledda A, Maggioni AP, Santoro L, Tognoni G (2001) Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data. Heart 86:527–532CrossRefPubMed Pizzetti F, Turazza FM, Franzosi MG, Barlera S, Ledda A, Maggioni AP, Santoro L, Tognoni G (2001) Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data. Heart 86:527–532CrossRefPubMed
29.
Zurück zum Zitat Figueras J, Pena C, Soler-Soler J (2005) Thirty day prognosis of patients with acute pulmonary oedema complicating acute coronary syndromes. Heart 91:889–893CrossRefPubMed Figueras J, Pena C, Soler-Soler J (2005) Thirty day prognosis of patients with acute pulmonary oedema complicating acute coronary syndromes. Heart 91:889–893CrossRefPubMed
30.
Zurück zum Zitat Marfella R, Nappo F, Marfella MA, Giugliano D (2001) Acute hyperglycemia and autonomic function. Diabetes Care 24:2016–2017CrossRefPubMed Marfella R, Nappo F, Marfella MA, Giugliano D (2001) Acute hyperglycemia and autonomic function. Diabetes Care 24:2016–2017CrossRefPubMed
Metadaten
Titel
Admission glucose level and in-hospital outcomes in diabetic and non-diabetic patients with acute myocardial infarction
verfasst von
Artur Dziewierz
Dawid Giszterowicz
Zbigniew Siudak
Tomasz Rakowski
Jacek S. Dubiel
Dariusz Dudek
Publikationsdatum
01.11.2010
Verlag
Springer-Verlag
Erschienen in
Clinical Research in Cardiology / Ausgabe 11/2010
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-010-0175-1

Weitere Artikel der Ausgabe 11/2010

Clinical Research in Cardiology 11/2010 Zur Ausgabe

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.